Promore Pharma is granted a patent for LL-37 in Japan

2019-08-27

STOCKHOLM, 27 August 2019 – Promore Pharma AB, a Swedish biopharmaceutical developer of therapeutic peptides, today announced that the company was granted a patent in Japan for the usage of LL-37 for treating chronic wounds.

Läs hela meddelandet på Promore Pharmas hemsida.